Bausch & Lomb

Valeant Pharmaceuticals, which owns a Rochester company with a long history in this area, will be adopting some of that heritage.

The Canadian pharmaceutical company that owns Bausch + Lomb will change its name to Bausch Health Companies effective in July.

The Fed decided last week to raise interest rates, we asked an RIT economist about who might feel the effects of that right away.

Also, a major investor in Valeant decided to sell his shares in the company, George Conboy of Brighton Securities ponders what that might mean for the future of B + L going forward.

The WXXI Business report looks at business and economic issues facing the Rochester area including Western New York and the Finger Lakes.

Canadian company Valeant Pharmaceuticals could cut as many as 500 Bausch + Lomb jobs in Rochester according to Lieutenant Governor Bob Duffy.

Duffy spoke to Valeant executives for about 20 minutes on a conference call Wednesday afternoon. He says nothing is certain until the company’s acquisition of Bausch + Lomb is closed.

However, he says they haven’t shifted on their plan to move the eye-care company’s headquarters to New Jersey, and cut up to 15 percent of the workforce.

Need To Know Rochester: The Business Section

Feb 4, 2013

Matt Daneman of the Democrat & Chronicle discusses the business news of the week including Constellation Brands and Bausch & Lomb.

Need To Know Rochester: The Business Section

Dec 14, 2012

Democrat & Chronicle business reporter Matt Daneman talks Kodak, regional economic development, and Bausch & Lomb with Julie Philipp.